Archives

by in
Entry Author Date Location
Flexion Overhaul Bears Fruit With Upbeat Data From Arthritis Trial 05/30/12 Boston
Abbott’s Humira, the 3rd-in-Class Drug That Toppled Lipitor as No. 1 04/16/12 National
Crescendo Bioscience Nabs $56M to Help Personalize Rheumatoid Arthritis Therapy 09/08/11 San Francisco
Arena Reloads for Round 2 with FDA, With More Data on Weight Loss Drug in Diabetes Patients 11/09/10 San Diego
Zalicus, Formerly the Bicoastal Biotech CombinatoRx, Seeks New Identity with Name Fit for a Warrior 09/20/10 Boston
It’s Time for Universities to Get More Nimble 09/02/10 San Francisco
Logical Therapeutics Snags $10M to Make Pain Relievers Safer on the Gut 05/21/10 Boston
Alder’s Long-Awaited Arthritis Data, Ikaria Plots $200M IPO, Emerald’s Resurrection, & More Seattle-Area Life Sciences News 05/20/10 Seattle
Roche, Biogen Halt Arthritis Study 03/08/10 Boston
Genomic Advances of the 2000s Will Demand an Informatics Revolution in the 2010s 01/14/10 National
It’s About Health Care, Not Health Insurance 09/28/09 Seattle
ConforMIS Shapes Corporate Expansion with $50M D Round 07/13/09 Boston
KaloBios Gets $12M Genzyme, Baxter 12/22/08 Boston
Alder Gets Early Christmas Present: FDA Slaps Down Its Rival, Roche 12/08/08 Seattle
Korean Biotech Opens Mass. Office 12/04/08 Boston
CombinatoRx Cuts 30 More Jobs, Wiping out Two-Thirds of Staff in Last Month 11/20/08 Boston
Oral Pill May Make Tough-to-Deliver RNAi Drugs Go Down Easy, RXi Says 11/13/08 Boston
CombinatoRx Cuts 45 Percent of Staff After Arthritis Drug Failure 11/04/08 Boston
Trubion Shares Leap, Drop, Leap Again After Encouraging Clinical Trial News 10/27/08 Seattle
ZymoGenetics Drug Trial Halted Because of Infection Risk 10/27/08 Seattle
ZymoGenetics Gets $21M From Bristol-Myers To Settle Patent Suit 10/23/08 Seattle
CombinatoRx Reckoning Arrives: Stock Crashes on Failed Arthritis Trial 10/06/08 Boston
CombinatoRx Judgment Day Coming Soon, Arthritis Drug Results On the Way 09/30/08 Boston
Ariad Loses Patent Case Against Amgen 09/22/08 Boston
Alder Sets Stage for Showdown With Roche, With “Fast Follower” Antibody Drug Strategy 09/18/08 Seattle
Trubion Pushing Forward Arthritis Trials, Working to Re-Ignite the Spark for Investors 08/26/08 Seattle
Taligen CEO Aims to Develop Drugs For Inflammatory Diseases, Build Company in Cambridge 08/14/08 Boston
Page 1 of 1

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.